HEDIS® Results
Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
|
Measure / Data Element |
2019 |
2020 |
2020 Goal |
|
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
NA |
NA |
67.47% |
|
Adult BMI Assessment (ABA) |
92.46% |
95.13% |
93.67% |
|
Annual Dental Visits (ADV) |
NB |
NB |
64.11% |
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
NA |
NA |
40.95% |
|
Appropriate Testing for Pharyngitis (CWP) |
73.76% |
76.13% |
86.51% |
|
Appropriate Treatment for Upper Respiratory Infection (URI) |
94.43% |
92.08% |
94.88% |
|
Asthma Medication Ratio (AMR) Total |
67.99% |
65.48% |
68.52% |
|
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
39.22% |
61.51% |
41.07% |
|
Breast Cancer Screening (BCS) |
40.36% |
40.00% |
63.98% |
|
Cervical Cancer Screening (CCS) |
53.28% |
54.99% |
66.49% |
|
Childhood Immunization Status (CIS) Combination #10 |
36.98% |
35.77% |
42.02% |
|
Chlamydia Screening in Women (CHL) Total |
39.95% |
41.14% |
66.24% |
|
Comprehensive Diabetes Care (CDC) BP Control < 140/90 |
67.64% |
75.67% |
71.44% |
|
Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0% |
47.69% |
54.26% |
55.96% |
|
Comprehensive Diabetes Care (CDC) Eye Exam |
52.31% |
52.07% |
64.72% |
|
Controlling High Blood Pressure (CBP) |
55.47% |
60.58% |
66.91% |
|
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
NA |
NA |
84.27% |
|
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
NB |
NB |
16.93% |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
NB |
NB |
49.65% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
NB |
NB |
42.69% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
NA |
NA |
62.69% |
|
Immunizations for Adolescents (IMA) Combination #2 |
27.74% |
27.49% |
40.39% |
|
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
NB |
NB |
18.12% |
|
Medication Management for People with Asthma (MMA) Medication Compliance 75% Total |
35.80% |
36.27% |
42.77% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total |
NA |
NA |
40.90% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
68.18% |
65.67% |
75.38% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
81.82% |
85.07% |
87.93% |
|
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
62.29% |
91.48% |
87.59% |
|
Prenatal and Postpartum Care (PPC) Postpartum Care |
52.80% |
74.70% |
69.83% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
75.47% |
72.55% |
81.24% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
45.00% |
48.65% |
69.97% |
|
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
59.44% |
56.82% |
67.19% |
|
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
58.78% |
68.00% |
66.42% |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
NB |
NB |
66.58% |
|
Use of Imaging Studies for Low Back Pain (LBP) |
66.89% |
73.21% |
76.02% |
|
Use of Opioids at High Dosage (HDO) |
8.16% |
12.54% |
≤ 2.27% |
|
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
3.80% |
2.47% |
≤ 2.14% |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
62.77% |
79.32% |
85.16% |
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate